Study of Patha (Cissampelos pareira L.) Powder for Better Lung Function in Respiratory Disease Patients (shwasa roga)

Phytochemical analysis and therapeutic efficacy of patha (Cissampelos pareira L.) Churna for improving the pulmonary function in patients of shwasa roga - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/111658

Enrollment

Registered

2026-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group of 20 to 60 years of either sex. 2 Patients having classical features of Tamak shwasa such as Swash kastata or dyspnea Ativegat Kasate or cough Ghurghurakam or wheezing Parsve Avagrihyate or chest tightness etc. 3 Spirometric criteria FEV1 equal to or greater than 80 percent and FEV1 by FVC ratio normal or mildly reduced 4 No acute exacerbation in last 4 to 6 weeks. 5 Patients willing to participate in study trial and give written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients on prolonged medication with corticosteroids, bronchodilators, mast cell stabilizers etc. in last 6 weeks. 2. Patients having respiratory diseases like tuberculosis, Pneumonia, Status Asthmaticus, Moderate/severe cases of COPD & asthma, Cystic fibrosis, Pleural effusion, Pneumothorax, Lung cancer and other systemic diseases like Severe anaemia, Liver & Renal disorders, Cardiovascular diseases and any other diagnosed cases of comorbidities. 3. Patients with uncontrolled diabetes mellitus and hypertension. 4. Patients who have completed participation in any other clinical trial during the past 6 months. 5. Pregnancy and lactating mother.

Design outcomes

Primary

Measure	Time frame
To evaluate the therapeutic effect of Patha (Cissampelos pareira L,) churn for improving the pulmonary function in patients of shwasa rogaTimepoint: 3 months	—

Secondary

Measure	Time frame
To perform the phytochemical analysis, pharmacognostical study of Patha (Cissampelos pareira L.) To evaluate the safety of Patha (Cissampelos pareira L.) for improving the pulmonary function in patients of shwasa roga. Timepoint: 3 Months	—

Countries

India

Contacts

Public ContactDr Banshidhar Behera

Ayurvedic and Unani Tibbia College and Hospital

drbanshi@rediffmail.com9414458895

Outcome results